CDNA Q2 2018 Earnings — CareDx, Inc Revenue & Financial Results | Market Cap Arena

CDNACareDx, Inc

$858M

Q2 2018 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$18M+48.0% YoY

Gross Profit

$11M59.6% margin

Operating Income

-$5M-29.2% margin

Net Income

-$14M-78.9% margin

EPS (Diluted)

$-0.40

QoQ Revenue Growth

+26.8%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$7M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$80M

Total Liabilities

$51M

Stockholders' Equity

$29M

Cash & Equivalents

$16M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$18M	$12M	+48.0%
Gross Profit	$11M	$7M	+54.8%
Operating Income	-$5M	-$4M	-44.7%
Net Income	-$14M	-$4M	-254.4%

Revenue Segments

Service

$14M79%

Product

$4M20%

License And Other

$276,0002%

Geographic Segments

Pre Transplant

$7M100%